Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. May 14, 2014; 20(18): 5308-5319
Published online May 14, 2014. doi: 10.3748/wjg.v20.i18.5308
Published online May 14, 2014. doi: 10.3748/wjg.v20.i18.5308
Table 1 Studies of external beam radiotherapy for hepatocellular carcinoma before liver transplant
Ref. | n | Medial dose (Gy)/fractions (n) | Tumor (n) | Size of tumor (cm) | Child C n (%) | Patients who failed previous LRT | Radiological CR/PR | Transplanted after EBRT | HCC recurrence after LT |
Sandroussi et al[50] | 10 | 33/6 | 2 (1-10) | 6.3 (2.2-10.8) | 1 (10) | 5 | 0/7 | 5 | 0 |
Andolino et al[13] | 60 | 48/3 | 1 (1-3) | 3.1 (1.0-6.5) | 0 | 23 | 18/24 | 23 | 2 |
Katz et al[14] | 18 | 50/10 | 1 (1-2) | 4.0 (1.2-6.5) | 4 (22) | 3 | 0/4 | 11 | 0 |
O'Connor et al[49] | 10 | 51/3 | 1 (1-2) | 3.4 (2.5-5.5) | 1 (10) | 4 | NA | 10 | 0 |
- Citation: Fujiki M, Aucejo F, Choi M, Kim R. Neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: Where do we stand? World J Gastroenterol 2014; 20(18): 5308-5319
- URL: https://www.wjgnet.com/1007-9327/full/v20/i18/5308.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i18.5308